Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug426 | Azithromycin 500Mg Oral Tablet Wiki | 0.71 |
| drug1640 | Glucose tablets Wiki | 0.71 |
| drug423 | Azithromycin 250 MG Wiki | 0.71 |
Navigate: Correlations HPO
There are 2 clinical trials
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.
Description: National Early Warning Score equal to zero is when patients recovered clinically. Respiration 14-20breaths/minute, oxygen saturation percent greater than 96, (without breathing aid), systolic blood pressure 111-180 mmhg, pulse 60-90 beats.minute, alert consciousness and 35.1-38 degree Celsius body temperature.
Measure: National Early Warning Score equal to zero Time: 3-5 DaysDescription: below 3.0 miligram/Liter of blood sample
Measure: C-reactive proteins Time: 3-5 DaysDescription: 1000 -4800 lymphocytes in 1 microliter of blood
Measure: Lymphocyte Count Time: 3-5daysDescription: less than 250 ng/mL, or less than 0.4 mcg/mL of blood sample
Measure: d-dimers Time: 3-5daysThis study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia
Description: Clinical recovery is defined as a complete resolution clinical signs appeared during the medical history and related to COVID-19.
Measure: Clinical recovery at day-14, from the start of treatment. Time: 14 daysDescription: RT-PCR will be realized in same laboratory
Measure: Viral Clearance via RT-PCR at day 5- 7-10 and day 14 Time: 5- 7-10 and day 14Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports